Fluorine in PDB 5ism: Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor
Enzymatic activity of Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor
All present enzymatic activity of Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor:
3.4.14.5;
Protein crystallography data
The structure of Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor, PDB code: 5ism
was solved by
G.Scapin,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.93 /
2.00
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
118.274,
126.029,
137.273,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
16.5 /
20.1
|
Other elements in 5ism:
The structure of Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor
(pdb code 5ism). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor, PDB code: 5ism:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 5ism
Go back to
Fluorine Binding Sites List in 5ism
Fluorine binding site 1 out
of 6 in the Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F811
b:15.3
occ:1.00
|
F27
|
A:6DG811
|
0.0
|
15.3
|
1.0
|
C12
|
A:6DG811
|
1.3
|
14.2
|
1.0
|
C13
|
A:6DG811
|
2.3
|
14.5
|
1.0
|
C2
|
A:6DG811
|
2.3
|
14.4
|
1.0
|
C19
|
A:6DG811
|
2.7
|
14.7
|
1.0
|
ND2
|
A:ASN710
|
3.1
|
12.6
|
1.0
|
NH2
|
A:ARG125
|
3.3
|
16.9
|
1.0
|
OE2
|
A:GLU205
|
3.3
|
12.8
|
1.0
|
N20
|
A:6DG811
|
3.4
|
13.7
|
1.0
|
OH
|
A:TYR662
|
3.5
|
11.7
|
1.0
|
OD1
|
A:ASN710
|
3.5
|
13.9
|
1.0
|
C3
|
A:6DG811
|
3.6
|
14.1
|
1.0
|
CG
|
A:ASN710
|
3.6
|
12.6
|
1.0
|
C1
|
A:6DG811
|
3.6
|
14.9
|
1.0
|
O
|
A:HOH1366
|
3.7
|
21.4
|
1.0
|
C18
|
A:6DG811
|
3.7
|
14.3
|
1.0
|
NE2
|
A:HIS740
|
3.7
|
13.9
|
1.0
|
CD2
|
A:HIS740
|
3.8
|
14.1
|
1.0
|
OG
|
A:SER630
|
3.9
|
14.8
|
0.4
|
O
|
A:HOH978
|
3.9
|
17.3
|
1.0
|
OG
|
A:SER630
|
3.9
|
15.3
|
0.6
|
O25
|
A:6DG811
|
3.9
|
15.2
|
1.0
|
C11
|
A:6DG811
|
4.0
|
15.1
|
1.0
|
CD
|
A:GLU205
|
4.5
|
13.6
|
1.0
|
CZ
|
A:TYR662
|
4.6
|
11.5
|
1.0
|
O
|
A:HOH1592
|
4.6
|
38.1
|
1.0
|
CZ
|
A:ARG125
|
4.7
|
17.1
|
1.0
|
C6
|
A:6DG811
|
4.7
|
14.7
|
1.0
|
CE1
|
A:HIS740
|
4.8
|
14.0
|
1.0
|
C7
|
A:6DG811
|
4.8
|
15.4
|
1.0
|
CB
|
A:ASN710
|
4.8
|
12.3
|
1.0
|
CG
|
A:HIS740
|
4.8
|
13.7
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 5ism
Go back to
Fluorine Binding Sites List in 5ism
Fluorine binding site 2 out
of 6 in the Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F811
b:16.1
occ:1.00
|
F26
|
A:6DG811
|
0.0
|
16.1
|
1.0
|
C11
|
A:6DG811
|
1.3
|
15.1
|
1.0
|
C1
|
A:6DG811
|
2.3
|
14.9
|
1.0
|
C3
|
A:6DG811
|
2.4
|
14.1
|
1.0
|
CD2
|
A:TYR631
|
3.5
|
12.9
|
1.0
|
C2
|
A:6DG811
|
3.6
|
14.4
|
1.0
|
C13
|
A:6DG811
|
3.6
|
14.5
|
1.0
|
CE1
|
A:TYR666
|
3.7
|
12.6
|
1.0
|
CH2
|
A:TRP659
|
3.8
|
11.7
|
1.0
|
CB
|
A:TYR631
|
3.9
|
13.0
|
1.0
|
CG2
|
A:VAL656
|
3.9
|
11.8
|
1.0
|
CZ
|
A:TYR666
|
3.9
|
13.0
|
1.0
|
OH
|
A:TYR666
|
3.9
|
13.6
|
1.0
|
CZ3
|
A:TRP659
|
4.0
|
11.8
|
1.0
|
C12
|
A:6DG811
|
4.1
|
14.2
|
1.0
|
CA
|
A:TYR631
|
4.1
|
12.7
|
1.0
|
N
|
A:TYR631
|
4.1
|
12.6
|
1.0
|
CG
|
A:TYR631
|
4.1
|
12.8
|
1.0
|
CE2
|
A:TYR662
|
4.2
|
11.6
|
1.0
|
CD1
|
A:TYR666
|
4.4
|
12.6
|
1.0
|
CZ
|
A:TYR662
|
4.4
|
11.5
|
1.0
|
CE2
|
A:TYR631
|
4.5
|
13.3
|
1.0
|
CD2
|
A:TYR662
|
4.5
|
11.7
|
1.0
|
OG
|
A:SER630
|
4.6
|
15.3
|
0.6
|
OG
|
A:SER630
|
4.6
|
14.8
|
0.4
|
OH
|
A:TYR662
|
4.7
|
11.7
|
1.0
|
CE2
|
A:TYR666
|
4.8
|
13.3
|
1.0
|
C19
|
A:6DG811
|
4.9
|
14.7
|
1.0
|
CB
|
A:VAL656
|
4.9
|
11.5
|
1.0
|
CE1
|
A:TYR662
|
4.9
|
11.7
|
1.0
|
CZ2
|
A:TRP659
|
5.0
|
12.0
|
1.0
|
C
|
A:SER630
|
5.0
|
13.1
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 5ism
Go back to
Fluorine Binding Sites List in 5ism
Fluorine binding site 3 out
of 6 in the Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F810
b:18.1
occ:0.60
|
F27
|
B:6DG810
|
0.0
|
18.1
|
0.6
|
F27
|
B:6DG810
|
0.6
|
9.7
|
0.4
|
C12
|
B:6DG810
|
1.3
|
9.8
|
0.4
|
C12
|
B:6DG810
|
1.3
|
18.7
|
0.6
|
C13
|
B:6DG810
|
2.2
|
9.6
|
0.4
|
C2
|
B:6DG810
|
2.3
|
9.8
|
0.4
|
C2
|
B:6DG810
|
2.4
|
18.5
|
0.6
|
C13
|
B:6DG810
|
2.4
|
18.9
|
0.6
|
C19
|
B:6DG810
|
2.8
|
9.4
|
0.4
|
C19
|
B:6DG810
|
2.8
|
19.5
|
0.6
|
NH2
|
B:ARG125
|
3.3
|
18.8
|
1.0
|
ND2
|
B:ASN710
|
3.4
|
13.0
|
1.0
|
C3
|
B:6DG810
|
3.5
|
9.8
|
0.4
|
C1
|
B:6DG810
|
3.5
|
10.0
|
0.4
|
O
|
B:HOH1010
|
3.5
|
22.8
|
1.0
|
O
|
B:HOH1431
|
3.5
|
25.9
|
1.0
|
NE2
|
B:HIS740
|
3.6
|
14.9
|
1.0
|
OE2
|
B:GLU205
|
3.6
|
16.5
|
1.0
|
CD2
|
B:HIS740
|
3.6
|
14.5
|
1.0
|
OD1
|
B:ASN710
|
3.6
|
13.0
|
1.0
|
OG
|
B:SER630
|
3.6
|
15.9
|
1.0
|
C1
|
B:6DG810
|
3.6
|
18.3
|
0.6
|
C3
|
B:6DG810
|
3.6
|
18.2
|
0.6
|
N20
|
B:6DG810
|
3.7
|
19.3
|
0.6
|
OH
|
B:TYR662
|
3.7
|
13.0
|
1.0
|
N20
|
B:6DG810
|
3.7
|
9.2
|
0.4
|
CG
|
B:ASN710
|
3.7
|
12.7
|
1.0
|
O25
|
B:6DG810
|
3.8
|
9.5
|
0.4
|
C18
|
B:6DG810
|
3.9
|
9.3
|
0.4
|
O25
|
B:6DG810
|
3.9
|
20.6
|
0.6
|
C18
|
B:6DG810
|
3.9
|
19.9
|
0.6
|
C11
|
B:6DG810
|
3.9
|
10.0
|
0.4
|
C11
|
B:6DG810
|
4.1
|
18.4
|
0.6
|
CZ
|
B:ARG125
|
4.6
|
19.9
|
1.0
|
C7
|
B:6DG810
|
4.6
|
9.3
|
0.4
|
CE1
|
B:HIS740
|
4.6
|
14.8
|
1.0
|
CG
|
B:HIS740
|
4.7
|
14.3
|
1.0
|
CD
|
B:GLU205
|
4.7
|
15.5
|
1.0
|
C7
|
B:6DG810
|
4.8
|
21.2
|
0.6
|
CZ
|
B:TYR662
|
4.8
|
12.8
|
1.0
|
CB
|
B:SER630
|
4.8
|
14.8
|
1.0
|
C6
|
B:6DG810
|
4.9
|
9.3
|
0.4
|
CB
|
B:ASN710
|
4.9
|
12.7
|
1.0
|
C6
|
B:6DG810
|
4.9
|
20.9
|
0.6
|
|
Fluorine binding site 4 out
of 6 in 5ism
Go back to
Fluorine Binding Sites List in 5ism
Fluorine binding site 4 out
of 6 in the Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F810
b:9.7
occ:0.40
|
F27
|
B:6DG810
|
0.0
|
9.7
|
0.4
|
F27
|
B:6DG810
|
0.6
|
18.1
|
0.6
|
C12
|
B:6DG810
|
1.3
|
9.8
|
0.4
|
C12
|
B:6DG810
|
1.5
|
18.7
|
0.6
|
C2
|
B:6DG810
|
2.3
|
9.8
|
0.4
|
C13
|
B:6DG810
|
2.4
|
9.6
|
0.4
|
C2
|
B:6DG810
|
2.5
|
18.5
|
0.6
|
C13
|
B:6DG810
|
2.5
|
18.9
|
0.6
|
C19
|
B:6DG810
|
2.8
|
9.4
|
0.4
|
C19
|
B:6DG810
|
2.9
|
19.5
|
0.6
|
ND2
|
B:ASN710
|
2.9
|
13.0
|
1.0
|
OE2
|
B:GLU205
|
3.2
|
16.5
|
1.0
|
OD1
|
B:ASN710
|
3.2
|
13.0
|
1.0
|
NH2
|
B:ARG125
|
3.2
|
18.8
|
1.0
|
OH
|
B:TYR662
|
3.3
|
13.0
|
1.0
|
CG
|
B:ASN710
|
3.3
|
12.7
|
1.0
|
N20
|
B:6DG810
|
3.4
|
19.3
|
0.6
|
N20
|
B:6DG810
|
3.4
|
9.2
|
0.4
|
C1
|
B:6DG810
|
3.6
|
10.0
|
0.4
|
C3
|
B:6DG810
|
3.6
|
9.8
|
0.4
|
C1
|
B:6DG810
|
3.7
|
18.3
|
0.6
|
C3
|
B:6DG810
|
3.7
|
18.2
|
0.6
|
C18
|
B:6DG810
|
3.8
|
9.3
|
0.4
|
C18
|
B:6DG810
|
3.8
|
19.9
|
0.6
|
CD2
|
B:HIS740
|
3.8
|
14.5
|
1.0
|
NE2
|
B:HIS740
|
3.9
|
14.9
|
1.0
|
O
|
B:HOH1431
|
3.9
|
25.9
|
1.0
|
O25
|
B:6DG810
|
4.0
|
9.5
|
0.4
|
O
|
B:HOH1010
|
4.0
|
22.8
|
1.0
|
C11
|
B:6DG810
|
4.1
|
10.0
|
0.4
|
OG
|
B:SER630
|
4.1
|
15.9
|
1.0
|
O25
|
B:6DG810
|
4.1
|
20.6
|
0.6
|
C11
|
B:6DG810
|
4.2
|
18.4
|
0.6
|
CD
|
B:GLU205
|
4.3
|
15.5
|
1.0
|
CZ
|
B:TYR662
|
4.4
|
12.8
|
1.0
|
CZ
|
B:ARG125
|
4.6
|
19.9
|
1.0
|
CB
|
B:ASN710
|
4.6
|
12.7
|
1.0
|
C6
|
B:6DG810
|
4.7
|
9.3
|
0.4
|
C7
|
B:6DG810
|
4.8
|
9.3
|
0.4
|
C6
|
B:6DG810
|
4.8
|
20.9
|
0.6
|
CG
|
B:HIS740
|
4.8
|
14.3
|
1.0
|
CE1
|
B:HIS740
|
4.9
|
14.8
|
1.0
|
C7
|
B:6DG810
|
4.9
|
21.2
|
0.6
|
CE1
|
B:TYR662
|
5.0
|
12.6
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 5ism
Go back to
Fluorine Binding Sites List in 5ism
Fluorine binding site 5 out
of 6 in the Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F810
b:18.2
occ:0.60
|
F26
|
B:6DG810
|
0.0
|
18.2
|
0.6
|
F26
|
B:6DG810
|
0.7
|
10.6
|
0.4
|
C11
|
B:6DG810
|
1.4
|
18.4
|
0.6
|
C11
|
B:6DG810
|
1.6
|
10.0
|
0.4
|
C3
|
B:6DG810
|
2.4
|
18.2
|
0.6
|
C1
|
B:6DG810
|
2.4
|
18.3
|
0.6
|
C3
|
B:6DG810
|
2.5
|
9.8
|
0.4
|
C1
|
B:6DG810
|
2.6
|
10.0
|
0.4
|
CE1
|
B:TYR666
|
3.4
|
15.2
|
1.0
|
CH2
|
B:TRP659
|
3.6
|
14.0
|
1.0
|
CD2
|
B:TYR631
|
3.6
|
14.3
|
1.0
|
C2
|
B:6DG810
|
3.7
|
18.5
|
0.6
|
C13
|
B:6DG810
|
3.7
|
18.9
|
0.6
|
CZ
|
B:TYR666
|
3.7
|
14.8
|
1.0
|
C13
|
B:6DG810
|
3.8
|
9.6
|
0.4
|
C2
|
B:6DG810
|
3.8
|
9.8
|
0.4
|
CZ3
|
B:TRP659
|
3.8
|
13.9
|
1.0
|
OH
|
B:TYR666
|
3.9
|
15.9
|
1.0
|
CG2
|
B:VAL656
|
3.9
|
13.6
|
1.0
|
CE2
|
B:TYR662
|
3.9
|
12.4
|
1.0
|
CD1
|
B:TYR666
|
4.0
|
14.5
|
1.0
|
CB
|
B:TYR631
|
4.1
|
14.5
|
1.0
|
C12
|
B:6DG810
|
4.1
|
18.7
|
0.6
|
CD2
|
B:TYR662
|
4.2
|
12.6
|
1.0
|
C12
|
B:6DG810
|
4.3
|
9.8
|
0.4
|
CZ
|
B:TYR662
|
4.3
|
12.8
|
1.0
|
CG
|
B:TYR631
|
4.3
|
14.4
|
1.0
|
CA
|
B:TYR631
|
4.4
|
14.2
|
1.0
|
N
|
B:TYR631
|
4.5
|
13.5
|
1.0
|
CE2
|
B:TYR631
|
4.5
|
14.6
|
1.0
|
CE2
|
B:TYR666
|
4.6
|
14.5
|
1.0
|
OH
|
B:TYR662
|
4.7
|
13.0
|
1.0
|
CG
|
B:TYR662
|
4.8
|
12.6
|
1.0
|
CE1
|
B:TYR662
|
4.8
|
12.6
|
1.0
|
CZ2
|
B:TRP659
|
4.9
|
14.3
|
1.0
|
CG
|
B:TYR666
|
4.9
|
14.2
|
1.0
|
C19
|
B:6DG810
|
4.9
|
19.5
|
0.6
|
OG
|
B:SER630
|
4.9
|
15.9
|
1.0
|
C19
|
B:6DG810
|
5.0
|
9.4
|
0.4
|
|
Fluorine binding site 6 out
of 6 in 5ism
Go back to
Fluorine Binding Sites List in 5ism
Fluorine binding site 6 out
of 6 in the Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human DPP4 in Complex with A Novel 5,5,6-Tricyclic Pyrrolidine Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F810
b:10.6
occ:0.40
|
F26
|
B:6DG810
|
0.0
|
10.6
|
0.4
|
F26
|
B:6DG810
|
0.7
|
18.2
|
0.6
|
C11
|
B:6DG810
|
1.3
|
18.4
|
0.6
|
C11
|
B:6DG810
|
1.3
|
10.0
|
0.4
|
C1
|
B:6DG810
|
2.2
|
18.3
|
0.6
|
C3
|
B:6DG810
|
2.3
|
18.2
|
0.6
|
C1
|
B:6DG810
|
2.4
|
10.0
|
0.4
|
C3
|
B:6DG810
|
2.4
|
9.8
|
0.4
|
CD2
|
B:TYR631
|
3.4
|
14.3
|
1.0
|
C2
|
B:6DG810
|
3.5
|
18.5
|
0.6
|
C13
|
B:6DG810
|
3.5
|
18.9
|
0.6
|
CB
|
B:TYR631
|
3.6
|
14.5
|
1.0
|
C2
|
B:6DG810
|
3.6
|
9.8
|
0.4
|
C13
|
B:6DG810
|
3.6
|
9.6
|
0.4
|
CA
|
B:TYR631
|
3.8
|
14.2
|
1.0
|
N
|
B:TYR631
|
3.8
|
13.5
|
1.0
|
CE1
|
B:TYR666
|
3.9
|
15.2
|
1.0
|
CH2
|
B:TRP659
|
3.9
|
14.0
|
1.0
|
CG
|
B:TYR631
|
4.0
|
14.4
|
1.0
|
CG2
|
B:VAL656
|
4.0
|
13.6
|
1.0
|
C12
|
B:6DG810
|
4.0
|
18.7
|
0.6
|
OH
|
B:TYR666
|
4.0
|
15.9
|
1.0
|
CZ
|
B:TYR666
|
4.1
|
14.8
|
1.0
|
C12
|
B:6DG810
|
4.1
|
9.8
|
0.4
|
CZ3
|
B:TRP659
|
4.3
|
13.9
|
1.0
|
OG
|
B:SER630
|
4.4
|
15.9
|
1.0
|
CE2
|
B:TYR662
|
4.5
|
12.4
|
1.0
|
CE2
|
B:TYR631
|
4.5
|
14.6
|
1.0
|
CD1
|
B:TYR666
|
4.6
|
14.5
|
1.0
|
CZ
|
B:TYR662
|
4.7
|
12.8
|
1.0
|
C
|
B:SER630
|
4.7
|
14.0
|
1.0
|
CD2
|
B:TYR662
|
4.8
|
12.6
|
1.0
|
C19
|
B:6DG810
|
4.8
|
19.5
|
0.6
|
OH
|
B:TYR547
|
4.9
|
21.6
|
1.0
|
C19
|
B:6DG810
|
4.9
|
9.4
|
0.4
|
O25
|
B:6DG810
|
4.9
|
20.6
|
0.6
|
CE2
|
B:TYR666
|
4.9
|
14.5
|
1.0
|
OH
|
B:TYR662
|
5.0
|
13.0
|
1.0
|
|
Reference:
J.M.Cox,
H.D.Chu,
J.T.Kuethe,
Y.D.Gao,
G.Scapin,
G.Eiermann,
H.He,
X.Li,
K.A.Lyons,
J.Metzger,
A.Petrov,
J.K.Wu,
S.Xu,
R.Sinha-Roy,
A.E.Weber,
T.Biftu.
The Discovery of Novel 5,6,5- and 5,5,6-Tricyclic Pyrrolidines As Potent and Selective Dpp-4 Inhibitors. Bioorg.Med.Chem.Lett. V. 26 2622 2016.
ISSN: ESSN 1464-3405
PubMed: 27106708
DOI: 10.1016/J.BMCL.2016.04.020
Page generated: Thu Aug 1 10:16:20 2024
|